Improving Methods to Assess Therapeutic Quality Control of Treatment with Oral Anticoagulants

Thromb Haemost 2000; 84(05): 920-921
DOI: 10.1055/s-0037-4140

Letters to the Editor

Schattauer GmbH

Autoren

Fernando Marco

¹From Servicio de Hematología, Hospital Universitario “Marqués de Valdecilla”, Santander, Spain
Carmen Sedano

¹From Servicio de Hematología, Hospital Universitario “Marqués de Valdecilla”, Santander, Spain
Arancha Bermúdez

¹From Servicio de Hematología, Hospital Universitario “Marqués de Valdecilla”, Santander, Spain
Mónica López Duarte

¹From Servicio de Hematología, Hospital Universitario “Marqués de Valdecilla”, Santander, Spain
Alberto Zubizarreta

¹From Servicio de Hematología, Hospital Universitario “Marqués de Valdecilla”, Santander, Spain

References
1 Hirsh J, Dalen JE, Anderson DR, Poller L, Bussey H, Ansell J, Deykin D, Brandt JT. Oral anticoagulants. Mechanisms of action, clinical effectiveness and optimal therapeutic range. Chest 1998; 114: 445S-69S.
2 Duxbury BmcD. Therapeutic control of anticoagulant treatment. Br Med J 1982; 284: 702-4.
3 Rosendaal FR, Cannegieter SC, Van der Meer FJM, Vandenbroucke JP, Briët E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993; 69: 236-9.
4 Hutten BA, Prins MH, Redekop WK, Tijssen JGP, Heisterkamp SH, Büller HR. Comparison of three methods to assess therapeutic quality control of treatment with vitamin K antagonists. Thromb Haemost 1999; 82: 1260-3.
5 Marco F, Lopez MDuarte, Sedano C, Bermudez A, Perez RMontes, Carreter E, Fernández EFontecha, Ontañon A, Conde E, Zubizarreta A. Computerised oral anticoagulant dosage: a prospective randomized study of 5568 tests. Blood 1999; 94 (suppl 1, part 2): 109b.